| Entry |
|
|---|
| Name |
Nalidixic acid (JP18/USP/INN);
NegGram (TN) |
|---|
| Formula |
C12H12N2O3
|
|---|
| Exact mass |
232.0848
|
|---|
| Mol weight |
232.23
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
|
|---|
| Remark |
|
|---|
| Efficacy |
Antibacterial, Nucleic acid biosynthesis inhibitor |
|---|
| Target |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01M QUINOLONE ANTIBACTERIALS
J01MB Other quinolones
J01MB02 Nalidixic acid
D00183 Nalidixic acid (JP18/USP/INN)
Drug groups [BR:br08330]
Antibacterial
DG01550 Quinolone
DG00630 Nalidixic acid
D00183 Nalidixic acid
Antimicrobials [BR:br08307]
Antibacterials
Nucleic acid synthesis inhibitor
Other quinolone
D00183 Nalidixic acid (JP18/USP/INN)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00183 Nalidixic acid
Pharmacogenomic biomarkers [br08341.html]
Polymorphisms and mutations affecting drug response
D00183
Drug groups [BR:br08330]
Antibacterial
DG01550 Quinolone
DG00630 Nalidixic acid
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Nucleic acid synthesis inhibitor
Other quinolone
DG00630 Nalidixic acid
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 17
1 C8y C 24.4685 -17.3910
2 C8y C 24.4685 -15.9905
3 N4y N 25.6963 -18.1008
4 N5x N 23.2472 -18.1071
5 C8y C 25.6836 -15.2743
6 C8x C 23.2472 -15.2936
7 C8x C 26.8773 -17.3975
8 C1b C 25.6899 -19.4883
9 C8y C 22.0386 -17.3910
10 C8y C 26.9113 -15.9776
11 O5x O 25.6770 -13.8803
12 C8x C 22.0386 -15.9905
13 C1a C 24.4878 -20.1854
14 C1a C 20.8301 -18.0816
15 C6a C 28.1134 -15.2807
16 O6a O 29.3221 -15.9713
17 O6a O 28.1706 -13.8868
BOND 18
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 3 8 1
8 4 9 2
9 5 10 1
10 5 11 2
11 6 12 2
12 8 13 1
13 9 14 1
14 10 15 1
15 15 16 1
16 15 17 2
17 7 10 2
18 9 12 1
|
|---|
